Antidepressant use in low- middle- and high-income countries: a World Mental Health Surveys report.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The most common treatment for major depressive disorder (MDD) is antidepressant medication (ADM). Results are reported on frequency of ADM use, reasons for use, and perceived effectiveness of use in general population surveys across 20 countries.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Psychol Med

Title: Psychological medicine

Publisher: Cambridge University Press (CUP)

ISSN (Electronic): 1469-8978

ISSN (Print): 0033-2917

Publication date (Electronic): Mar 2023

Volume: 53

Issue: 4

Affiliations

[1 ] Department of Psychology, Yale University, New Haven, CT, USA.

[2 ] Department of Psychiatry, National Taiwan University Hospital & College of Medicine, Taipei, Taiwan.

[3 ] Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.

[4 ] College of Medicine, Al-Qadisiya University, Diwaniya governorate, Al Diwaniyah, Iraq.

[5 ] Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain.

[6 ] Pompeu Fabra University (UPF), Barcelona, Spain.

[7 ] CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.

[8 ] Núcleo de Epidemiologia Psiquiátrica - LIM 23, Instituto de Psiquiatria Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Brazil.

[9 ] Department of Epidemiologic and Psychosocial Research, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.

[10 ] Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), NOVA Medical School | Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.

[11 ] IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.

[12 ] Department of Developmental Psychology, University of Groningen, Groningen, The Netherlands.

[13 ] Interdisciplinary Center Psychopathology and Emotion Regulation, University Medical Center Groningen, Groningen, The Netherlands.

[14 ] National School of Public Health, Management and Development, Bucharest, Romania.

[15 ] Department of Psychiatry, University College Hospital, Ibadan, Nigeria.

[16 ] Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat, Barcelona, Spain.

[17 ] School of Public Health, The University of Queensland, Herston, QLD 4006, Australia.

[18 ] Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol QLD 4072, Australia.

[19 ] Faculty of Medicine, Department of Psychiatry and Clinical Psychology, St George Hospital University Medical Center, Balamand University, Beirut, Lebanon.

[20 ] Institute for Development, Research, Advocacy and Applied Care (IDRAAC), Beirut, Lebanon.

[21 ] Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057, Paris Descartes University, Paris, France.

[22 ] Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong.

[23 ] Queensland Brain Institute, The University of Queensland, St Lucia QLD 4065, Australia.

[24 ] National Centre for Register-based Research, Aarhus University, Aarhus V 8000, Denmark.

[25 ] UDIF-SM, Servicio Murciano de Salud; IMIB-Arrixaca; CIBERESP-Murcia, Región de Murcia, Spain.

[26 ] Department of Mental Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

[27 ] National Center of Neurology and Psychiatry, Tokyo, Japan.

[28 ] Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia.

[29 ] Department of Psychiatry & Mental Health and South African Medical Council Research Unit on Risk and Resilience in Mental Disorders, University of Cape Town, Cape Town, South Africa.

[30 ] Groote Schuur Hospital, Cape Town, South Africa.

[31 ] Department of Psychiatry, Koç University, Istanbul, Turkey.

[32 ] Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.

[33 ] Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.

[34 ] Department of Mental Health, National Center of Public Health and Analyses, Sofia, Bulgaria.

Article

Mid ID: NIHMS1778399 Publisher Item ID: S0033291721003160

DOI: 10.1017/S0033291721003160

PMC ID: 10071359

PubMed ID: 37010212

SO-VID: 8cc2974d-1e59-4a09-8c90-b1d4ff8b21fd

History

Keywords: reasons for use,Antidepressant medications,perceived effectiveness

Data availability:

Keywords: reasons for use, Antidepressant medications, perceived effectiveness

Comments

Comment on this article

scite_

Cited by 4

See all cited by